Micralyne & MicroCHIPS Form Strategic Research & Development Partnership
Edmonton, Alberta and Cambridge, Massachusetts, September 3, 2002 - Micralyne Inc. and MicroCHIPS, Inc. today announced that they have entered into an agreement for the development of MicroCHIPS' innovative silicon chips for drug delivery.
Micralyne, a developer and OEM and manufacturer of BioMEMS and other MEMS components, will work with MicroCHIPS as MicroCHIPS continues device development and proceeds towards clinical trials.
"We believe that the technology that MicroCHIPS is developing for implantable MEMS-based drug delivery has the potential to be an important step forward for the effective implementation of therapeutic regimens in the future", commented Chris Lumb, President and CEO of Micralyne. "We are excited to be involved in this work with MicroCHIPS, and pleased to be working for the first time in drug delivery, a relatively new area for BioMEMS applications."
John Santini, President and Chief Scientific Officer of MicroCHIPS, Inc. added, "It is a challenge to find a MEMS foundry having the experience of an OEM manufacturer and the willingness to work with a medical company during product development when volumes are low. Micralyne has the capability and experience to produce quality product at both low and high volumes. We look forward to working with Micralyne in the coming months."
About MicroCHIPS
MicroCHIPS, Inc. is a pioneer in the development of advanced drug delivery systems. The company's patented technology is designed for the controlled administration of both protein and small molecule drugs for use in pain management, hormone and steroid delivery, and some cancer and CNS disorders. MicroCHIPS was founded in 1999 by John Santini, Terry McGuire, and MIT Professors Robert Langer and Michael Cima.
About Micralyne
Micralyne develops and manufactures microfabricated and MEMS (Micro-Electro-Mechanical-Systems)-based products. Micralyne is one of the largest independent companies in the world that manufactures MEMS in high volumes. MEMS technology is built on the premise of making industrial components smaller, faster and less expensive and facilitates radical improvements in the miniaturization of electronic and mechanical devices. These types of devices are used in many industries including communications, automotive, aerospace, and life sciences. More specifically, Micralyne’s micron-scale solutions (i.e. 1000 microns = 1 millimetre) are found in automotive emission sensors, optical switching technology in telecommunication networks, lab-on-a-chip devices for drug discovery, and commercial press equipment for printing today’s most popular magazines. Micralyne is a profitable and growing company headquartered in Edmonton, Alberta, Canada.
For further information contact:
Mr. Chris Lumb
President & CEO
Micralyne Inc.
1911 - 94 Street
Edmonton, Alberta
Canada T6N 1E6
Phone: 780-431-4400
clumb@micralyne.com
Dr. John Santini
President & CSO
MicroCHIPS, Inc.
45 Spinelli Place
Cambridge, MA 02138
Tel: (617) 492-3900
www.mchips.com
